Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check4 days agoChange DetectedThis updates the site’s displayed revision/version label for the ClinicalTrials.gov page (from v3.5.2 to v3.5.3) without changing the study content.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded the term Malignant fibrous histiocytoma to related terms and added Genetic and Rare Diseases Information Center as a resources reference.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to core study details or user-facing content.SummaryDifference0.0%

- Check47 days agoChange DetectedPage revision updated to v3.4.3 (March 2026); prior revision details (v3.4.2) and September 2025 entries were removed.SummaryDifference0.3%

- Check75 days agoChange DetectedRevision: v3.4.2 added; the notice about government funding lapse and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.